Hughes Financial Services, LLC Celldex Therapeutics, Inc. Transaction History
Hughes Financial Services, LLC
- $511 Billion
- Q1 2025
A detailed history of Hughes Financial Services, LLC transactions in Celldex Therapeutics, Inc. stock. As of the latest transaction made, Hughes Financial Services, LLC holds 24 shares of CLDX stock, worth $499. This represents 0.0% of its overall portfolio holdings.
Number of Shares
24Holding current value
$499% of portfolio
0.0%Shares
1 transactions
Others Institutions Holding CLDX
# of Institutions
200Shares Held
60.6MCall Options Held
960KPut Options Held
675K-
Kynam Capital Management, LP Princeton, NJ5.06MShares$105 Million8.11% of portfolio
-
Black Rock Inc. New York, NY4.69MShares$97.7 Million0.0% of portfolio
-
Vanguard Group Inc Valley Forge, PA3.88MShares$80.9 Million0.0% of portfolio
-
Eventide Asset Management, LLC Boston, MA3.75MShares$78.2 Million1.82% of portfolio
-
Price T Rowe Associates Inc Baltimore, MD3.56MShares$74.1 Million0.01% of portfolio
About Celldex Therapeutics, Inc.
- Ticker CLDX
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 46,772,400
- Market Cap $974M
- Description
- Celldex Therapeutics, Inc., a biopharmaceutical company, engages in developing therapeutic monoclonal and bispecific antibodies for the treatment of various diseases. Its drug candidates include antibody-based therapeutics to treat patients with inflammatory diseases and various forms of cancer. The company's clinical development programs CDX-01...